Piper Sandler Issues Positive Forecast for Quest Diagnostics (NYSE:DGX) Stock Price
Quest Diagnostics (NYSE:DGX – Get Free Report) had its price target lifted by investment analysts at Piper Sandler from $180.00 to $200.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the medical research company’s stock. Piper Sandler’s target price suggests a potential upside of 11.78% from the […]
Quest Diagnostics (NYSE:DGX – Get Free Report) had its price target lifted by investment analysts at Piper Sandler from $180.00 to $200.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the medical research company’s stock. Piper Sandler’s target price suggests a potential upside of 11.78% from the […]
